US equities
|
NVDA
$178.67
▲+0.00%
MU
$733.15
▲+0.00%
AMD
$508.58
▲+0.00%
SNDK
$886.51
▲+0.00%
SPCX
$142.07
▲+0.00%
SKHY
$134.38
▲+0.00%
TSLA
$378.05
▲+0.00%
TSM
$388.62
▲+0.00%
NVDA
$178.67
▲+0.00%
MU
$733.15
▲+0.00%
AMD
$508.58
▲+0.00%
SNDK
$886.51
▲+0.00%
SPCX
$142.07
▲+0.00%
SKHY
$134.38
▲+0.00%
TSLA
$378.05
▲+0.00%
TSM
$388.62
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
BKV Corporation Common Stock
(NY:
BKV
)
18.42
UNCHANGED
Delayed Quote
Updated: 7:00 PM EST, Nov 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BKV Corporation Common Stock
< Previous
1
2
3
4
5
Next >
BKV's Integrated Operations Offer Value, Analyst Highlights Unique 'Closed-Loop' System And Growth Prospects
↗
October 25, 2024
Truist Securities analyst initiates Buy rating & $24 price target for BKV Corporation, owned by Banpu with potential for future equity sales.
Via
Benzinga
This PPL Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
↗
October 25, 2024
Via
Benzinga
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
October 21, 2024
Via
Benzinga
Self-Driving Startup Pony.ai Files For U.S. IPO
↗
October 20, 2024
Self-driving startup Pony.ai of China filed for an IPO in the U.S. this week. Meanwhile, four companies -- Springview Holdings, Oriental Rise Holdings, PTL Limited, and Samfine Creation Holdings Group...
Via
Talk Markets
Topics
Initial Public Offering
Obesity Drug Developer BioAge Makes Nasdaq Debut
↗
September 29, 2024
Shares of BioAge Labs opened for trading this week, with the company planning to use the proceeds of its initial public offering to take its lead obesity drug further into clinical trials.
Via
Talk Markets
BKV Corporation Announces Closing of Initial Public Offering
September 27, 2024
From
BKV Corporation
Via
Business Wire
< Previous
1
2
3
4
5
Next >